.On April 26, 2023, Congresswoman Carol Miller (R-WV) released the following statement on the passage of the Limit, Save, Grow Act of 2023 in the House of Representatives.
Congresswoman Carol Miller (R-WV) reintroduced the Manufacturing API, Drugs, and Excipients (MADE) in America Act to prevent U.S. pharmaceutical supply chain dependence on China and other foreign adversaries.
During a Ways and Means Committee hearing, Congresswoman Carol Miller (R-WV) questioned witnesses on the U.S. tax code subsidizing green corporate handouts and the Chinese Communist Party.
On April 18, 2023, Congresswoman Carol Miller (R-WV) joined the Ways and Means Trade Subcommittee hearing on Countering China’s Trade and Investment Agenda.